Synthesis and pharmacological screening of 1-chloro-3-(2-propynyloxy)-2-propanols and 2-((2-propynyloxy)methyl)oxiranes.
D000433:1-Propanol / Q000138:chemical synthesis* / Q000627:therapeutic use; D000477:Alkylating Agents / Q000138:chemical synthesis / Q000627:therapeutic use; D000480:Alkynes / Q000138:chemical synthesis / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002728:Chlorohydrins; D004852:Epoxy Compounds; D004988:Ethers, Cyclic / Q000138:chemical synthesis* / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D008815:Mice, Inbred Strains; D013055:Spectrophotometry, Infrared; D013329:Structure-Activity Relationship
D000477:Alkylating Agents; D000480:Alkynes; D000970:Antineoplastic Agents; D002728:Chlorohydrins; D004852:Epoxy Compounds; D004988:Ethers, Cyclic; C009075:2-((2-propynyloxy)methyl)oxirane; C007023:1-chloro-3-(2-propynyloxy)-2-propanol; D000433:1-Propanol